Lori J. Braender
2023
In 2023, Lori J. Braender earned a total compensation of $1.2M as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary at Aquestive Therapeutics, a 28% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $263,942 |
|---|---|
| Salary | $417,300 |
| Stock Awards | $480,750 |
| Other | $31,973 |
| Total | $1,193,965 |
Braender received $480.8K in stock awards, accounting for 40% of the total pay in 2023.
Braender also received $263.9K in non-equity incentive plan, $417.3K in salary and $32K in other compensation.
Rankings
In 2023, Lori J. Braender's compensation ranked 930th out of 2,338 executives tracked by ExecPay. In other words, Braender earned more than 60.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 930 out of 2,338 | 60th |
Division Manufacturing | 551 out of 1,259 | 56th |
Major group Chemicals And Allied Products | 378 out of 711 | 47th |
Industry group Drugs | 368 out of 682 | 46th |
Industry Pharmaceutical Preparations | 252 out of 493 | 49th |
Source: SEC filing on April 26, 2024.
Braender's colleagues
We found two more compensation records of executives who worked with Lori J. Braender at Aquestive Therapeutics in 2023.